News
As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...
Novavax (NasdaqGS:NVAX) recently announced promising preliminary results from the SHIELD-Utah study, which highlighted fewer and less severe reactogenicity symptoms for its COVID-19 Vaccine, ...
Novavax shifts to a partnership-focused strategy with a $500M Sanofi deal. Despite regulatory and competitive risks. See why ...
Health secretary Robert F. Kennedy Jr. has expressed another unorthodox view on vaccines, declaring that single antigen ...
Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...
An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.
One of the FDA’s recently departed top officials is weighing in on the wide-ranging staff cuts at the agency and how they ...
The health secretary has chipped away at the idea that immunizing children against measles and other diseases is a public health good.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results